1. Home
  2. NMM vs HTFL Comparison

NMM vs HTFL Comparison

Compare NMM & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navios Maritime Partners LP

NMM

Navios Maritime Partners LP

HOLD

Current Price

$88.56

Market Cap

2.2B

ML Signal

HOLD

Logo Heartflow Inc.

HTFL

Heartflow Inc.

HOLD

Current Price

$49.64

Market Cap

2.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMM
HTFL
Founded
2007
2007
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.2B
IPO Year
2007
2025

Fundamental Metrics

Financial Performance
Metric
NMM
HTFL
Price
$88.56
$49.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$85.00
$38.20
AVG Volume (30 Days)
108.4K
1.8M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
0.34%
N/A
EPS Growth
N/A
82.37
EPS
N/A
N/A
Revenue
N/A
$176,034,000.00
Revenue This Year
$5.57
$27.66
Revenue Next Year
$3.66
$23.55
P/E Ratio
$7.24
N/A
Revenue Growth
N/A
39.92
52 Week Low
$43.02
$20.13
52 Week High
$87.66
$47.95

Technical Indicators

Market Signals
Indicator
NMM
HTFL
Relative Strength Index (RSI) 77.31 88.58
Support Level $69.21 $24.59
Resistance Level N/A N/A
Average True Range (ATR) 2.14 2.39
MACD 0.62 2.31
Stochastic Oscillator 90.13 98.08

Price Performance

Historical Comparison
NMM
HTFL

About NMM Navios Maritime Partners LP

Navios Maritime Partners LP is an international owner and operator of dry cargo and tanker vessels. Its vessels are generally chartered-out under short-term, medium-term and long-term time charters with an average remaining charter duration of approximately 2.1 years to a group of counterparties. Its fleet consisted of dry bulk vessels, containerships and tanker vessels, including two newbuilding capesize vessels, newbuilding containerships and newbuilding tankers. It operates in single segment.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Share on Social Networks: